M&A in pharma sees deals worth $14.8 bn in Nov 2024 EP News Bureau Dec 9, 2024 According to GlobalData, M&A deal value declined by 2 per cent, and venture capital investments decreased by 5 per cent in…
Golden moment for India in key sectors including pharma over next 10 years: Venture capitalist Press Trust of India Jul 19, 2020 Indian ministers, key bureaucrats and technology industry leaders should put together a roadmap, set of regulations and…
Lonza to expand viral gene therapy biz EP News Bureau Jul 7, 2015 Plans to construct a new state-of-the-art 100,000 square foot facility (9,300 square metres) in the Houston, TX
